Tumor hypoxia is one of the physiological factors for treatment resistance and likely contributes to poor overall survival among patients with head and neck ca…

Head and Neck CancerHypoxiaMagnetic Resonance Imaging+1 more

~Estimated

~$10 – $750

University of UtahNCT06108089

Phase 1

A Pilot Study of Neoadjuvant Cemiplimab With Platinum-Doublet Chemotherapy, and Cetuximab in Patients With Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

The purpose of this study is to find out whether combining the standard chemotherapy for head and neck cancer with the immunotherapy drugs cetuximab and cemipl…

Head and Neck CancerHead CancerHead Cancer Neck+3 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT04722523